尿サンプルにおける細胞異質性と経路の動態を解読:急性腎損傷を理解するためのUMAPベースのアプローチ
Cheng Yuan1,2,3, Juan Wu4, Yuandi Xiang5
1Department of Oncology, Yichang Central People's Hospital and The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China.
Frontiers in pharmacology
|September 3, 2025
まとめ
急性腎臓損傷 (AKI) は,腎臓機能の急速な喪失を伴う. この研究では,MAPK1がAKI患者で上昇調節され,腎繊維症のバイオマーカーおよび治療標的として機能する可能性があることが判明しました.
科学分野:
- 腎臓科
- ゲノミクス
- 免疫学
背景:
- 急性腎損傷 (AKI) は,腎機能の急速な低下と重度の臨床結果を持つ重大な状態です.
- 尿の細胞多様性を理解することで 病気のメカニズムと治療戦略の洞察が得られます
研究 の 目的:
- ユニフォーム・マニフォールド・アプロシマーション (UMAP) を用いて,AKI尿の細胞組成と遺伝子発現を調査する.
- AKIの病理生理学に関連した細胞の相互作用と経路の活性化を特定する.
主な方法:
- 遺伝子表現オムニバス (GEO) データベースから公開されているGSE180595データセットの分析
- AKIと非AKI患者の尿単核細胞の単細胞RNA配列解析 (scRNA-seq)
- ECMに関連する経路とMAPK1定量化に焦点を当てた差異的遺伝子発現分析.
主要な成果:
- UMAPは,AKIのサンプルと非AKIのサンプルで,AKIの単細胞のような免疫細胞が増えたことを明らかにしました.
- 経路分析では,AKI細胞におけるDNA複製とECM関連遺伝子の活性化が強化され,損傷と再構成における役割を示唆した.
- ECMに関連する経路はAKIで著しく強化され,MAPK1が重要な調節遺伝子として特定されました.
結論:
- MAPK1は,AKI患者の尿単核細胞で上昇調節され,ECMに関連する経路を調節する.
- MAPK1は,AKIの診断/予後バイオマーカーであり,ECMの改造と線維症の治療標的となる可能性がある.
- AKIの治療におけるMAPK1の臨床的有用性を調べるためにさらなる研究が必要である.
さらに関連する動画
関連する概念動画
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:22Acute Kidney Injury I: Introduction
72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:29Acute Kidney Injury III: Clinical Manifestations
90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44